“Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity” published in Cancer Research

Masaoki Kawasumi’s paper on small-molecule screening for novel ATR pathway inhibitors was published online in Cancer Research. “Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity.”